医学
遗传诊断
基因检测
疾病
医学诊断
遗传咨询
重症监护医学
新生儿筛查
植入前遗传学诊断
产前诊断
遗传性疾病
生物信息学
人类遗传学
儿科
梅德林
遗传关联
遗传变异
范围(计算机科学)
家庭医学
全基因组测序
医学遗传学
基因歧视
作者
Han Lianshu,Yonglan Huang,Jingkun Miao
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-09-10
卷期号:43 (9): 641-656
标识
DOI:10.3760/cma.j.cn511374-20260202-00061
摘要
With the application of high-throughput sequencing technology in neonatal genetic disease screening, the scope of screened diseases has significantly expanded. However, after recall and further examination of positive screening results, physicians may encounter difficulties in the diagnosis, treatment, and follow-up. To tackle these, the Screening Group of Neonatal Genetic Metabolic Disease, Special Committee for Birth Defects Prevention and Control, Chinese Preventive Medicine Association has organized experts from relevant fields. By referencing domestic and international expert consensuses and research findings on disease diagnosis and treatment, a consensus has been formulated through multiple rounds of discussions. It has summarized the principles for confirming, excluding, and suspecting diagnoses in neonates with positive genetic screening results, with typical genetic diseases across different systems used as examples. These include genetic metabolic disorders, hematological genetic diseases, immunodeficiency disorders, neuromuscular genetic diseases, hereditary kidney diseases, hereditary hearing loss, and hereditary eye diseases. The aim is to provide standardized and practical guidance for neonatal genetic screening, promote standardized and efficient screening practices, improve early diagnosis rates for genetic diseases, further optimize follow-up and management strategies, and improve the prognosis of patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI